Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

296 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
When mutants gain new powers: news from the mutant p53 field.
Brosh R, Rotter V. Brosh R, et al. Nat Rev Cancer. 2009 Oct;9(10):701-13. doi: 10.1038/nrc2693. Epub 2009 Aug 20. Nat Rev Cancer. 2009. PMID: 19693097 Review.
p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner.
Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, Rinon A, Tzahor E, Lozano G, Zipori D, Sarig R, Rotter V. Molchadsky A, et al. PLoS One. 2008;3(11):e3707. doi: 10.1371/journal.pone.0003707. Epub 2008 Nov 12. PLoS One. 2008. PMID: 19002260 Free PMC article.
The role of p53 in base excision repair following genotoxic stress.
Zurer I, Hofseth LJ, Cohen Y, Xu-Welliver M, Hussain SP, Harris CC, Rotter V. Zurer I, et al. Carcinogenesis. 2004 Jan;25(1):11-9. doi: 10.1093/carcin/bgg186. Epub 2003 Oct 10. Carcinogenesis. 2004. PMID: 14555612
Novel p53 target genes secreted by the liver are involved in non-cell-autonomous regulation.
Charni M, Molchadsky A, Goldstein I, Solomon H, Tal P, Goldfinger N, Yang P, Porat Z, Lozano G, Rotter V. Charni M, et al. Cell Death Differ. 2016 Mar;23(3):509-20. doi: 10.1038/cdd.2015.119. Epub 2015 Sep 11. Cell Death Differ. 2016. PMID: 26358154 Free PMC article.
p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity.
Molchadsky A, Ezra O, Amendola PG, Krantz D, Kogan-Sakin I, Buganim Y, Rivlin N, Goldfinger N, Folgiero V, Falcioni R, Sarig R, Rotter V. Molchadsky A, et al. Cell Death Differ. 2013 May;20(5):774-83. doi: 10.1038/cdd.2013.9. Epub 2013 Feb 15. Cell Death Differ. 2013. PMID: 23412343 Free PMC article.
p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition.
Brosh R, Assia-Alroy Y, Molchadsky A, Bornstein C, Dekel E, Madar S, Shetzer Y, Rivlin N, Goldfinger N, Sarig R, Rotter V. Brosh R, et al. Cell Death Differ. 2013 Feb;20(2):312-20. doi: 10.1038/cdd.2012.125. Epub 2012 Sep 21. Cell Death Differ. 2013. PMID: 22996684 Free PMC article.
Mutant p53 protein, master regulator of human malignancies: a report on the Fifth Mutant p53 Workshop.
Blandino G, Deppert W, Hainaut P, Levine A, Lozano G, Olivier M, Rotter V, Wiman K, Oren M. Blandino G, et al. Cell Death Differ. 2012 Jan;19(1):180-3. doi: 10.1038/cdd.2011.148. Epub 2011 Nov 18. Cell Death Differ. 2012. PMID: 22095277 Free PMC article. No abstract available.
Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation.
Aylon Y, Yabuta N, Besserglick H, Buganim Y, Rotter V, Nojima H, Oren M. Aylon Y, et al. Oncogene. 2009 Dec 17;28(50):4469-79. doi: 10.1038/onc.2009.270. Epub 2009 Oct 26. Oncogene. 2009. PMID: 19855428 Free PMC article.
Cancer cells suppress p53 in adjacent fibroblasts.
Bar J, Feniger-Barish R, Lukashchuk N, Shaham H, Moskovits N, Goldfinger N, Simansky D, Perlman M, Papa M, Yosepovich A, Rechavi G, Rotter V, Oren M. Bar J, et al. Oncogene. 2009 Feb 12;28(6):933-6. doi: 10.1038/onc.2008.445. Epub 2008 Dec 8. Oncogene. 2009. PMID: 19060923 Free PMC article.
296 results
Jump to page
Feedback